Adjunctive middle meningeal artery embolization for non-acute subdural hematoma: A GRADE-assessed meta-analysis and trial sequential analysis on randomized trials
Acta Neurochirurgica · 02.06.2025 · 167 (1)
DOI: 10.1007/s00701-025-06574-9 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Acta Neurochirurgica, online erschienen am 02.06.2025. Verfasst von Mohamed S Elgendy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Tanta University, Tanta, Egypt. Dr.elgendy.mo@gmail.com. Hauptthemen laut MEDLINE: Meningeal Arteries, Embolization, Therapeutic, Hematoma, Subdural. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tanta University.
Abstract (Originalsprache)
Background and Purpose Non-acute subdural hematoma (NASDH) is a prevalent neurological condition, encompassing chronic and subacute types. Despite standard-care, including surgical evacuation and medical management, recurrence rates remain high. Emerging evidence suggests that middle meningeal artery embolization (MMAE) as an adjunctive procedure may reduce recurrence. This study evaluates the efficacy and safety of MMAE in NASDH.
Methods
A systematic review and meta-analysis of randomized controlled trials (RCTs) retrieved from PubMed, EMBASE, WOS, Scopus, and Cochrane until November 2024. The analysis presented risk ratios (RR) for dichotomous outcomes and mean differences (MD) for continuous outcomes, with 95% confidence intervals (CI) using R software. The GRADE system assessed evidence certainty, alongside trial sequential analysis for result reliability. PROSPERO ID: CRD42024625504.
Results
Six RCTs and 1,544 patients were included, with an average of 4.7 months follow-up. Adjunctive MMAE, compared to standard-care, significantly reduced hematoma recurrence (8% vs 15.6%; RR: 0.52; 95% CI: [0.37:0.73]; P < 0.01) and surgical rescue (4.5% vs. 12.7%; RR: 0.36; 95% CI: [0.25:0.53]; P < 0.01). However, no significant effect was found for recurrence without surgery ( P = 0.94), hematoma volume ( P = 0.18), thickness ( P = 0.34), or hospital stay ( P = 0.37). Infection rates were higher with MMAE (8.4% vs. 4.8%; RR: 1.81; 95% CI: [1.23:2.66]; P < 0.01), but adverse events (AEs), serious AEs, intracranial hemorrhage, stroke, and mortality showed no significant differences.
Conclusion
Adjunctive MMAE reduced hematoma recurrence and surgical rescue rates in NASDH with an acceptable safety profile despite increased infection rates. However, further large-scale trials with extended follow-ups are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Tanta University, Tanta, Egypt. Dr.elgendy.mo@gmail.com.
- Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt.
- Faculty of Medicine, Fayoum University, Fayoum, Egypt.
- Faculty of Medicine, Tanta University, Tanta, Egypt.
- Neurology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
ORCID-Profile: Mohamed S Elgendy
Förderung
- Tanta University
Zitieren
APA
Elgendy, M. S., Rifai, M., Taha, A. M., Faheem, M. A., Taha, H. I., Meshref, M., Elewidi, M., & Abuelazm, M. (2025). Adjunctive middle meningeal artery embolization for non-acute subdural hematoma: A GRADE-assessed meta-analysis and trial sequential analysis on randomized trials. Acta Neurochirurgica, 167(1). https://doi.org/10.1007/s00701-025-06574-9
Vancouver
Elgendy MS, Rifai M, Taha AM, Faheem MA, Taha HI, Meshref M, et al. Adjunctive middle meningeal artery embolization for non-acute subdural hematoma: A GRADE-assessed meta-analysis and trial sequential analysis on randomized trials. Acta Neurochirurgica. 2025;167(1). doi:10.1007/s00701-025-06574-9
BibTeX
@article{Elgendy2025,
author = {Elgendy, Mohamed S and Rifai, Mohamed and Taha, Amira M and Faheem, Mohamed A and Taha, Hosam I and Meshref, Mostafa and Elewidi, Mariam and Abuelazm, Mohamed},
title = {Adjunctive middle meningeal artery embolization for non-acute subdural hematoma: A GRADE-assessed meta-analysis and trial sequential analysis on randomized trials},
journal = {Acta Neurochirurgica},
year = {2025},
volume = {167},
number = {1},
doi = {10.1007/s00701-025-06574-9}
}
EUVIMED